Cephalon’s Leukemia Drug Treanda Gets the FDA Clearance
By Anna Boyd
11:45, March 21st 2008
38 votes
Vote this story
Cephalon’s Leukemia Drug Treanda Gets the FDA Clearance

The U.S. Food and Drug Administration has approved Cephalon Inc.’s injectable drug, Treanda to treat chronic lymphocytic leukemia.

Chronic lymphocytic leukemia, or CLL, is a slowly progressing blood and bone marrow disease. Over time, the CLL cells multiply and replace normal lymphocytes in the marrow and lymph nodes. CLL signs and symptoms usually develop slowly. Some CLL patients may have no signs or symptoms in the early stages of the disease and may have little or no change to their health for many years.

CLL more often hits older adults with an average age of 70 and is more common in men than in women.

According to the American Cancer Society, more than 15,000 new cases of the rare disease will be diagnosed in the United States this year.

“Treanda is an important new treatment for patients with chronic lymphocytic leukemia, and this first-cycle approval by FDA represents a significant milestone in the growth of our oncology business. With a strong pipeline of near- and longer-term opportunities, Cephalon Oncology is poised to deliver therapies that target both hematologic cancers and solid tumors for patients in need of new options,” said Dr. Lesley Russell, Executive Vice President, Worldwide Medical and Regulatory Operations, Bizjournals.com reports.

The approval was granted after Cephalon submitted a study of 301 previously untreated CLL patients who were randomly assigned to receive Treanda or another chemotherapy treatment called chlorambucil. According to the results of the trial, fifty-nine percent of patients responded to Treanda compared with 26 percent who were treated with the other drug. Also, 8 percent of patients administered Treanda had a complete remission of their leukemia, compared with less than 1 percent in the other group.

The side effects of Treanda are similar to those inducted by other chemotherapy drugs, including fewer white blood cells, nausea, anemia and vomiting.

Cephalon expects Treanda to be available for U.S. physicians and patients in April. The company would not disclose the drug’s price until it is launched, Jenifer Antonacci, Cephalon’s representative said.

For Cephalon, launching Treanda could bring a much-needed boost. The company has seen its share price plunge about 29 percent since June, largely because of slowed prescription growth of Provigil, a therapy prescribed for narcolepsy, sleep apnea, and shift-work sleep disorder. Last month, shares hit a 52-week low of $56.20.



© 2007 - 2008 - eFluxMedia
Share the News:
Del.icio.us Digg Stumble Upon Facebook Newsvine Mixx
dotclear

Other News in

Calcium, Height Linked with Prostate Cancer

Calcium, Height Linked with Prostate Cancer

Men with high-normal levels of calcium in their blood, as well as men with above-average height, are more likely to suffer from prostate cancer.Researchers from four universities in England found...

Bisphenol A Causes Health Issues In Primates

Bisphenol A Causes Health Issues In Primates

A study conducted by a team of researchers at the Yale School of Medicine has connected bisphenol A (BPA) to health problems in primates, including brain function and mood...

Scientists Fail To Find MMR Vaccine - Autism Link

Scientists Fail To Find MMR Vaccine - Autism Link

Scientists with the Mailman School of Public Health Center for Infection and Immunity at Columbia University College of Physicians and Surgeons have found that there is no link between the...

Fire Retardant Chemicals Detected In Children’s Blood

Fire Retardant Chemicals Detected In Children’s Blood

According to The Environmental Working Group, a fire retardant chemical employed in electronics, toys and furniture has been spotted in kids’ blood at triple the levels found in their mothers.As...

High Levels of Serum Calcium Ups Prostate Cancer Death Risk

High Levels of Serum Calcium Ups Prostate Cancer Death Risk

Men with high levels of calcium in their blood are three times more likely to develop prostate cancer, a disease that may be fatal in some cases, a new report shows. The results could help...

dotclear
Latest videos in Health
Olympic Swimmer Has Cancer...
Dorm Room Bedbugs
Dogs Can Smell Skin Cancer?
HealthWatch
Allergy Attacks At School

dotclear
Health You are here: Health
» Science   » Health   
E-mail To A Friend Print RSS Text size: Decrease font size Increase font size
dotclear
dotclear
dotclear
Most Popular in Health
Older fathers Are More Likely To Have Children With Bipolar DisorderOlder fathers Are More Likely To Have Children With Bipolar Disorder

» read full story
dotclear

Interested In This Topic?

News Alert will keep you informed. Find out more.
dotclear
Photos Gallery
dotclear
Today's Latest News
Dell Brings You Dell Inspiron Mini 9Dell Brings You Dell Inspiron Mini 9

» read full story
dotclear